Literature DB >> 35127983

An Alternative Technique for Monitoring the Live Interaction of Monocytes and Tumor Cells with Nanoparticles in the Mouse Lung.

Fernanda Ramos-Gomes1, Nathalia Ferreira1, Frauke Alves1,2, M Andrea Markus1.   

Abstract

Nanomaterials are increasingly used for the diagnosis and treatment of cancer, including lung cancer. For the clinical translation of nano-based theranostics, it is vital to detect and monitor their accumulation in the tumor, as well as their interaction with tumor, immune cells, and the tumor microenvironment (TME). While high resolution microscopy of fixed tumor specimens can provide some of this information from individual thin slices, it cannot capture cellular events over time and lacks 3D information of the tumor tissue. On the other hand, in vivo optical procedures either fall short of providing the necessary cellular resolution, as in the case of epifluorescence optical imaging, or are very demanding, as for instance intravital lung microscopy. We describe an alternative approach to investigate nanoparticle-cell interactions in entire mouse lung lobes, by longitudinal live cell confocal microscopy at nanometer resolution. By filling the lung ex vivo with 1% agarose, we were able to stabilize the lung lobes and visualize the interaction of fluorescent cells and nanoparticles for at least 4 hours post mortem. This high resolution ex vivo live cell imaging approach is an easy 4D tool for assessing several dynamic processes in tumor tissue, such as the traffic of cells, shedding of extracellular vesicles (EVs), and the accumulation of nanoparticles in tumor tissue. Graphic abstract: Schematic of the workflow for live cell imaging in the mouse lung.
Copyright © 2022 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Cell dynamics; Fluorescence microscopy; Live cell imaging; Nanoparticles; TME

Year:  2022        PMID: 35127983      PMCID: PMC8799661          DOI: 10.21769/BioProtoc.4293

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

1.  Nanoparticles: Emerging carriers for drug delivery.

Authors:  Sagar R Mudshinge; Amol B Deore; Sachin Patil; Chetan M Bhalgat
Journal:  Saudi Pharm J       Date:  2011-04-21       Impact factor: 4.330

Review 2.  Delivering nanomedicine to solid tumors.

Authors:  Rakesh K Jain; Triantafyllos Stylianopoulos
Journal:  Nat Rev Clin Oncol       Date:  2010-09-14       Impact factor: 66.675

Review 3.  Cancer nanomedicine: progress, challenges and opportunities.

Authors:  Jinjun Shi; Philip W Kantoff; Richard Wooster; Omid C Farokhzad
Journal:  Nat Rev Cancer       Date:  2016-11-11       Impact factor: 60.716

4.  FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).

Authors:  Patricia Anne Dinndorf; Joseph Gootenberg; Martin H Cohen; Patricia Keegan; Richard Pazdur
Journal:  Oncologist       Date:  2007-08

Review 5.  Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies.

Authors:  Asiri Ediriwickrema; W Mark Saltzman
Journal:  ACS Biomater Sci Eng       Date:  2015-01-13

Review 6.  Interaction of biomedical nanoparticles with the pulmonary immune system.

Authors:  Fabian Blank; Kleanthis Fytianos; Emilie Seydoux; Laura Rodriguez-Lorenzo; Alke Petri-Fink; Christophe von Garnier; Barbara Rothen-Rutishauser
Journal:  J Nanobiotechnology       Date:  2017-01-09       Impact factor: 10.435

7.  Ex vivo Live Cell Imaging of Nanoparticle-Cell Interactions in the Mouse Lung.

Authors:  Fernanda Ramos-Gomes; Nathalia Ferreira; Alexander Kraupner; Frauke Alves; M Andrea Markus
Journal:  Front Bioeng Biotechnol       Date:  2020-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.